EUVIMEDEUVIMED entdecken
Open Access

Silencing of SIVA‑1 promotes cisplatin resistance in gastric cancer via the Bcl‑2/BAX‑mediated mitochondria‑dependent apoptosis pathway

Zheng-Yi Shi, Zheng-Rong Ding, Yu-Liang Huang, Yuan-Rui Lei, Hai-Bin Huang, Yan Qing, Miao-Ren Deng, Xu-Man Lu, Xu-Dong Dong, Long-Jie Xia, Sheng Xu, Xiao-Gang Zhong und 3 weitere

Oncology Reports · 13.03.2026 · 55 (5) · 1-15

DOI: 10.3892/or.2026.9100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 13.03.2026. Verfasst von Zheng-Yi Shi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anal Surgery, People's Hospital of Guangxi Zhuang Autonomous Region and Institute of Minimally Invasive Technology and A…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cisplatin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCisplatinDrug Resistance, NeoplasmHumansAnimalsProto-Oncogene Proteins c-bcl-2Micebcl-2-Associated X ProteinCell Line, TumorApoptosisXenograft Model Antitumor AssaysMitochondriaCell ProliferationCell MovementMice, NudeGene Expression Regulation, NeoplasticSignal TransductionGene SilencingAntineoplastic AgentsMaleApoptosis Regulatory Proteins

Stichwörter der Autor:innen

Bcl‑2SIVA‑1bioinformatics analysisdrug resistancegastric cancer

Substanzen

CisplatinProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinSIVA1 protein, humanBAX protein, humanBCL2 protein, humanAntineoplastic AgentsApoptosis Regulatory Proteins

Autor:innen und Institutionen

  • Department of Colorectal and Anal Surgery, People's Hospital of Guangxi Zhuang Autonomous Region and Institute of Minimally Invasive Technology and Applications, Guangxi Academy of Medical Sciences, Nanning, Guangxi Zhu…
  • The Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong 528400, P.R. China.
  • Graduate School, Guangxi Medical University, Nanning, People's Republic of China, Guangxi Zhuang Autonomous Region 530021, P.R. China.
  • Departments of Gastrointestinal, Hernia and Enterofistula Surgery, People's Hospital of Guangxi Zhuang Autonomous Region and Institute of Minimally Invasive Technology and Applications, Guangxi Academy of Medical Scienc…
  • Department of Cosmetic Plastic Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

Zitieren

APA

Shi, Z. Y., Ding, Z. R., Huang, Y. L., Lei, Y. R., Huang, H. B., Qing, Y., Deng, M. R., Lu, X. M., Dong, X. D., Xia, L. J., Xu, S., Zhong, X. G., Li, L., Kong, F. B., & Wang, X. T. (2026). Silencing of SIVA‑1 promotes cisplatin resistance in gastric cancer via the Bcl‑2/BAX‑mediated mitochondria‑dependent apoptosis pathway. Oncology Reports, 55(5), 1-15. https://doi.org/10.3892/or.2026.9100

Vancouver

Shi ZY, Ding ZR, Huang YL, Lei YR, Huang HB, Qing Y, et al. Silencing of SIVA‑1 promotes cisplatin resistance in gastric cancer via the Bcl‑2/BAX‑mediated mitochondria‑dependent apoptosis pathway. Oncology Reports. 2026;55(5):1-15. doi:10.3892/or.2026.9100

BibTeX
@article{Shi2026,
  author = {Shi, Zheng-Yi and Ding, Zheng-Rong and Huang, Yu-Liang and Lei, Yuan-Rui and Huang, Hai-Bin and Qing, Yan and Deng, Miao-Ren and Lu, Xu-Man and Dong, Xu-Dong and Xia, Long-Jie and Xu, Sheng and Zhong, Xiao-Gang and Li, Lei and Kong, Fan-Biao and Wang, Xiao-Tong},
  title = {Silencing of SIVA‑1 promotes cisplatin resistance in gastric cancer via the Bcl‑2/BAX‑mediated mitochondria‑dependent apoptosis pathway},
  journal = {Oncology Reports},
  year = {2026},
  volume = {55},
  number = {5},
  pages = {1--15},
  doi = {10.3892/or.2026.9100}
}
Kostenlos starten →